News

Published on 16 May 2024 on GuruFocus.com via Yahoo Finance

Director Jessica Hopfield Acquires 45,000 Shares of Editas Medicine Inc

Article preview image

On May 13, 2024, Jessica Hopfield, Director at Editas Medicine Inc (NASDAQ:EDIT), purchased 45,000 shares of the company, as reported in the SEC Filing. This transaction increased the insider's total holdings in the company to 67,700 shares.

Warning! GuruFocus has detected 5 Warning Signs with EDIT.

Editas Medicine Inc (NASDAQ:EDIT) is a biotechnology company focused on developing transformative gene editing therapies to treat a broad range of diseases.

Read the rest of the article
NASDAQ.EDIT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce

Editas stock falls as it ends development of reni-cel for SCD and TDT following failed attempts t...

Zacks · via Yahoo Finance 16 Dec 2024
Gene-editing pioneer Editas lays off more than half its employees - Boston...

Big changes, including major layoffs, are coming at Editas Medicine Inc. as the biotech lays off ...

The Business Journals 13 Dec 2024
Editas Medicine Realigns Strategy to Focus on In Vivo Gene Editing, Targets...

On Thursday, Editas Medicine Inc. (NASDAQ:EDIT) announced a strategic realignment to focus on in...

Benzinga · via Yahoo Finance 13 Dec 2024
Is Editas Medicine, Inc. (EDIT) a Promising Gene Editing Stock?

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge...

Insider Monkey · via Yahoo Finance 31 Oct 2024
State Street Corp's Strategic Reduction in Editas Medicine Inc Holdings

Overview of Recent Transaction by State Street Corp On September 30, 2024, State Street Corp exec...

GuruFocus.com · via Yahoo Finance 17 Oct 2024
What Makes Editas Medicine, Inc. (EDIT) One of the Best Small-Cap Stocks with...

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 19 Jun 2024
Is Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now?

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 19 Jun 2024
EVP, Chief Financial Officer Erick Lucera Sells 22,337 Shares of Editas Medicine Inc

Erick Lucera, the EVP, Chief Financial Officer of Editas Medicine Inc (NASDAQ:EDIT), sold 22,337 ...

GuruFocus.com via Yahoo Finance 23 May 2024
Director Jessica Hopfield Acquires 45,000 Shares of Editas Medicine Inc

On May 13, 2024, Jessica Hopfield, Director at Editas Medicine Inc (NASDAQ:EDIT), purchased 45,00...

GuruFocus.com via Yahoo Finance 16 May 2024
Editas Medicine, Inc. (NASDAQ:EDIT) Consensus Forecasts Have Become A Little Darker Since Its Latest...

Editas Medicine, Inc. (NASDAQ:EDIT) just released its latest quarterly report and things are not ...

Simply Wall St. via Yahoo Finance 9 May 2024

Copyright Statfolio @ 2024

Social Accounts